Loading...
Nanoparticle formulation of ormeloxifene for pancreatic cancer
Pancreatic cancer is the fourth most prevalent cancer with about an 85% mortality rate; thus, an utmost need exists to discover new therapeutic modalities that would enhance therapy outcomes of this disease with minimal or no side effects. Ormeloxifene (ORM), a synthetic molecule, has exhibited pote...
Na minha lista:
Udgivet i: | Biomaterials |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2015
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4405677/ https://ncbi.nlm.nih.gov/pubmed/25890768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2015.02.082 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|